Navidea Biopharmaceuticals (NAVB +2.3%) is set to close higher after announcing that the...

|About: Navidea Biopharmaceuticals (NAVB)|By:, SA News Editor

Navidea Biopharmaceuticals (NAVB +2.3%) is set to close higher after announcing that the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing intends to switch to using NAVB's Fluorine-18 labeled amyloid imaging candidate, NAV4694, for its research initiative on Alzheimer's disease and mild cognitive impairment.